close
close

Positive interim blood sugar results from Lexaria’s GLP-1 diabetes animal study

Posted on by Vaseline
Positive interim blood sugar results from Lexaria’s GLP-1 diabetes animal study

KELOWNA, BC / ACCESSWIRE / August 21, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX) & (NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announces that it has …

Related Posts